Clinical trials planning and execution (icon)
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75A50120D00017
- Awardee
-
Icon Government And Public Health Solutions, Inc. UEI JHJ7HXD5XR47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Task orders
- 7 $383,527,393 obligated
Award facts
- Opportunity
-
- Clinical Studies Network (CSN) Clinical Trial Planning and Execution (CTPE) Pre-Solicitation · 75A50119R00026 · Posted Sep 6, 2019
- BARDA Clinical Studies Network – Clinical Trial Planning & Execution (CTPE) Award Notice · Posted Sep 26, 2020
- Combined order value
-
- $383,527,393 Current, with exercised options
- $386,739,323 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 70% used
- $550,000,000.00
- Maximum order
- $400,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 11 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
Icon Government and Public Health Solutions, Inc., a foreign-owned clinical research organization based in Blue Bell, Pennsylvania, was awarded a single-award Indefinite Delivery/Indefinite Quantity contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services for Clinical Trials Planning and Execution services. The contract, valued at $550 million with an ultimate completion date of September 27, 2025, was awarded on September 28, 2020, following a pre-solicitation opportunity posted by the Biomedical Advanced Research and Development Authority (BARDA) in September 2019. The scope encompasses comprehensive clinical trial support services to advance development of medical countermeasures for chemical, biological, radiological, nuclear, pandemic influenza, and emerging infectious disease threats. Core service offerings include project management, site selection and monitoring, specimen and product management, regulatory support, protocol development, data management, participant recruitment, and regulatory submissions for both routine and emergency response clinical studies.
Multiple delivery orders have been issued under this IDIQ vehicle, reflecting Icon's significant role in supporting ASPR's medical countermeasure development initiatives. Substantial task orders include a $330.2 million award for clinical trial planning and execution supporting next-generation COVID-19 vaccine development (completion April 11, 2025); a $34.5 million award for H5 flu clinical trial planning and execution (completion March 30, 2026); a $13.1 million award for the Anthrax AV7909 Boost Evaluation and Antigen-Sparing Trial (ABEAST) (completion September 12, 2027); and an $8.3 million award for Sniff Study support. All work is performed in Hinckley, Ohio, under cost-plus-fixed-fee pricing structures with no set-aside designations, indicating open competition. These task orders demonstrate Icon's extensive capacity to execute complex clinical trials for medical countermeasure development across multiple therapeutic domains in support of national health security and emergency preparedness objectives.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $82,010 |
Show all 24
Quick answers
Who was awarded contract 75A50120D00017?
75A50120D00017 was awarded to Icon Government And Public Health Solutions, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 28, 2020.
How much is contract 75A50120D00017 worth?
Orders under 75A50120D00017 have obligated $383,527,393. Their combined potential value, with all options, is $386,739,323. 75A50120D00017's own ceiling is $550,000,000. A single order can be worth up to $400,000,000.
How many orders have been placed under contract 75A50120D00017?
7 orders have been placed under 75A50120D00017, the latest on September 27, 2023.
Who can order from contract 75A50120D00017?
75A50120D00017 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75A50120D00017 competed?
The extent of competition for 75A50120D00017 was full and open competition. The government received 11 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV